We have located links that may give you full text access.
Journal Article
Randomized Controlled Trial
Reversal of neuromuscular blockade with sugammadex or neostigmine/atropine: Effect on postoperative gastrointestinal motility.
Journal of Clinical Anesthesia 2016 August
STUDY OBJECTIVE: To compare sugammadex with conventional reversal of neuromuscular block in terms of postoperative gastrointestinal motility.
DESIGN: Double blinded, randomized, controlled clinical trial.
SETTING: Operating room, postoperative recovery area.
PATIENTS: Seventy-two patients with ASA physical status I or II, scheduled for total thyroid surgery were studied.
INTERVENTIONS: When 4 twitches were observed on train-of-four stimulation, neuromuscular block was reversed conversatively in the control group, and with sugammadex in the study group.
MEASUREMENTS: Time to first flatus and feces, incidence of postoperative nausea, vomiting, diarrhea and constipation were collected.
MAIN RESULTS: Median time of first flatus was 24 hours (18-32 [10-36]) in the neostigmine group, and 24 (18-28 [12-48]) in the sugammadex group (P > .05). Median (IQR) time of first feces was 24 hours (18-36 [10-48]) in neostigmine group, 32 hours (28-36 [12-72]) in sugammadex group (P > .05). There were no occurrences of nausea, vomiting, diarrhea, or constipation.
CONCLUSIONS: Sugammadex may be safely used in cases where postoperative ileus is expected.
DESIGN: Double blinded, randomized, controlled clinical trial.
SETTING: Operating room, postoperative recovery area.
PATIENTS: Seventy-two patients with ASA physical status I or II, scheduled for total thyroid surgery were studied.
INTERVENTIONS: When 4 twitches were observed on train-of-four stimulation, neuromuscular block was reversed conversatively in the control group, and with sugammadex in the study group.
MEASUREMENTS: Time to first flatus and feces, incidence of postoperative nausea, vomiting, diarrhea and constipation were collected.
MAIN RESULTS: Median time of first flatus was 24 hours (18-32 [10-36]) in the neostigmine group, and 24 (18-28 [12-48]) in the sugammadex group (P > .05). Median (IQR) time of first feces was 24 hours (18-36 [10-48]) in neostigmine group, 32 hours (28-36 [12-72]) in sugammadex group (P > .05). There were no occurrences of nausea, vomiting, diarrhea, or constipation.
CONCLUSIONS: Sugammadex may be safely used in cases where postoperative ileus is expected.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app